Clinical trials
Phase 3 Essential Hypertension trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 10 |
| 2023 | 3 |
| 2024 | 7 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 35 |
| Recruiting | 3 |
| Unknown status | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boryung Pharmaceutical Co., Ltd | 10 |
| Chong Kun Dang Pharmaceutical | 7 |
| Addpharma Inc. | 5 |
| Novartis Pharmaceuticals | 3 |
| Ahn-Gook Pharmaceuticals Co.,Ltd | 2 |
| Daewoong Pharmaceutical Co. LTD. | 2 |
| HK inno.N Corporation | 2 |
| Handok Inc. | 2 |
| AJU Pharm Co., Ltd. | 1 |
| Autotelicbio | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Essential Hypertension | 41 |
| Hypertension | 9 |
| Dyslipidemias | 3 |
| Diabetes Mellitus, Type 2 | 2 |
| Hypercholesterolemia | 1 |
| Hyperlipidemias | 1 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.